%0 Journal Article
%T Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant
%J Archive of "Pharmacy and Therapeutics".
%D 2019
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534172/